Sobel Alan D. 4
4 · Cytosorbents Corp · Filed Mar 3, 2020
Insider Transaction Report
Form 4
Sobel Alan D.
Director
Transactions
- Award
Stock Option (right to buy)
2020-02-28+15,000→ 15,000 totalExercise: $6.03Exp: 2030-02-28→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Includes 15,000 stock options granted on 2/28/2020 and reported on this Form 4. These options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan and will vest in four equal parts on 3/31/2020, 6/30/2020, 9/30/2020 and 12/31/2020.